Watch CNBC’s full interview with former Federal Reserve Governor Frederic Mishkin
New Federal Reserve Chair Warsh emphasizes political independence, signals focus on inflation
By CHRISTOPHER RUGABER, AP Economics Writer
WASHINGTON (AP) — New Federal Reserve Chair Kevin Warsh said Wednesday that the central bank would remain independent and seek to bring down inflation, likely foreclosing the rate cuts President Donald Trump has sought.
In remarks at a central bank conference in Sintra,
Read MoreCharles Payne on the future of tech stocks, gas prices and more
FOX Business’ Charles Payne discusses the second-quarter market rally, the future of tech and robot stocks and when gas prices will truly drop on ‘Fox & Friends.’ He also takes questions from the studio audience on investments and economic trends.
FOX Business’ Charles Payne analyzes the impressive market rally from the second quarter of 2025,
» Read more about: Charles Payne on the future of tech stocks, gas prices and more »
Read MoreBreaking: As QuantRate Launches Its Free AI Trading Bot, the AI Investing Trend Accelerates the Transformation of Global Financial Markets
QuantRate has launched a free AI trading bot, marking another step in the rapid growth of AI investing. Discover how AI is reshaping investing, automated trading, and the future of global financial markets.
London, United Kingdom , July 01, 2026 (GLOBE NEWSWIRE) — Global financial markets are entering a new phase of transformation as artificial intelligence continues to reshape how people invest and trade.
Want $2,000 a Month Without Selling a Single Share? These 4 Dividend ETFs Deliver
Quick Read
-
SCHD and VYM lead a four-fund dividend strategy targeting $24,000 yearly while every share stays intact in your brokerage account.
-
Reaching $2,000 monthly requires roughly $600,000 to $800,000 invested, but spreading across four ETFs ensures no single dividend cut wrecks your budget.
The Burst
1 Bitcoin Miner You Cannot Afford To Miss
Shares of bitcoin miner CleanSpark, Inc. (NASDAQ:CLSK) soared more than bitcoin over the past six months. However, the stock lost its momentum over the past month and declined by more than 11%.
The stock underwent significant volatility due to their correlation with bitcoin’s movement.
» Read more about: 1 Bitcoin Miner You Cannot Afford To Miss »
Read MoreThe Ivy
1 Titan Health Stock Is Way Too Cheap
Merck & Co. (NYSE: MRK) might be best known for its drugs like Keytruda and Gardasil, but those blockbusters haven’t been enough to get shareholders excited as the share price has fallen under water this year, down 6%.
It may well be a pharmaceutical powerhouse but recent price weakness suggests that Merck may be flying under the radar for investors,
» Read more about: 1 Titan Health Stock Is Way Too Cheap »
Read MoreThe Spotlight
